Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease
Overview
Authors
Affiliations
Background: Human immunodeficiency virus (HIV) infection is an independent risk factor for coronary heart disease (CHD) and is associated with perturbation of the gut microbiota.
Methods: We analyzed gut microbiota in 30 HIV-infected individuals with CHD (CHD+) and 30 without CHD (CHD-) of the HIV-HEART study group.
Results: Gut microbiota linked to CHD was associated with lower α-diversity. Despite insignificant differences in β-diversity, co-occurrence networks of bacterial genera clearly diverged between CHD+ and CHD- individuals. Multidimensional scaling separated HIV-infected individuals into 2 microbiome clusters, dominated by the genus Prevotella or Bacteroides. The relative abundance of 49 other genera was significantly different between both clusters. The Prevotella-rich cluster was largely composed of men who have sex with men (MSM) (97%), whereas the Bacteroides-rich cluster comprised both MSM (45%) and heterosexual individuals (55%). MSM of the Bacteroides-rich cluster were characterized by reduced α-diversity, advanced immunological HIV stage, longer antiretroviral therapy with more ART regimens, and longer use of protease inhibitors, compared with Prevotella-rich MSM.
Conclusions: Community structures of gut microbiota rather than individual species might facilitate risk assessment of CHD in HIV-infected individuals. Sexual behavior appears to be an important factor affecting gut microbiota β-diversity and should be considered in future studies.
HIV, the gut microbiome and clinical outcomes, a systematic review.
Mac Cann R, Newman E, Devane D, Sabin C, Cotter A, Landay A PLoS One. 2024; 19(12):e0308859.
PMID: 39652612 PMC: 11627425. DOI: 10.1371/journal.pone.0308859.
Gut microbiome and cardiometabolic comorbidities in people living with HIV.
Troseid M, Nielsen S, Vujkovic-Cvijin I Microbiome. 2024; 12(1):106.
PMID: 38877521 PMC: 11177534. DOI: 10.1186/s40168-024-01815-y.
Huang K, Amend L, Galvez E, Lesker T, de Oliveira R, Bielecka A Cell Rep Med. 2024; 5(3):101426.
PMID: 38366600 PMC: 10982974. DOI: 10.1016/j.xcrm.2024.101426.
Troseid M, Molinaro A, Gelpi M, Vestad B, Kofoed K, Fuchs A J Infect Dis. 2024; 229(3):898-907.
PMID: 38195204 PMC: 10938217. DOI: 10.1093/infdis/jiad604.
Moretti S, Schietroma I, Sberna G, Maggiorella M, Sernicola L, Farcomeni S Int J Mol Sci. 2023; 24(15).
PMID: 37569570 PMC: 10418605. DOI: 10.3390/ijms241512193.